tiprankstipranks
Trending News
More News >
Filana Therapeutics, Inc. (FLNA)
NASDAQ:FLNA
US Market

Filana Therapeutics (FLNA) Income Statement

Compare
3,925 Followers

Filana Therapeutics Income Statement

Last quarter (Q4 2025), Filana Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Filana Therapeutics's net income was $-12.54M. See Filana Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -936.00K$ 0.00$ -89.42M$ -68.03M$ 0.00
Operating Expenses
$ 94.45M$ 141.45M$ 16.53M$ 11.99M$ 32.87M
Depreciation and Amortization
$ 936.00K$ 1.13M$ 1.53M$ 1.30M$ 534.00K
EBITDA
$ -94.45M$ -141.15M$ -104.43M$ -78.72M$ -32.33M
Operating Income
$ -95.39M$ -141.45M$ -105.96M$ -80.02M$ -32.87M
Other Income/Expenses
$ 4.42M$ 117.10M$ 8.74M$ 3.77M$ 483.00K
Pretax Income
$ -90.97M$ -24.34M$ -97.22M$ -76.25M$ -32.38M
Net Income
$ -90.97M$ -24.34M$ -97.22M$ -76.25M$ -32.38M
Per Share Metrics
Basic EPS
$ -1.88$ -0.53$ -2.32$ -1.80$ -0.81
Diluted EPS
$ -1.88$ -0.52$ -2.32$ -1.80$ -0.81
Weighted Average Shares Outstanding
48.30M 46.33M 41.93M 40.20M 39.41M
Weighted Average Shares Outstanding (Diluted)
48.30M 46.60M 41.93M 40.20M 39.41M
Currency in USD

Filana Therapeutics Earnings and Revenue History